Objective: To examine the effects of the consumption of ®sh oils on the gene expression of lipoprotein lipase (LPL, EC 3.1.1.34) in human adipose tissue. In order to measure LPL mRNA in adipose tissue samples obtained by needle biopsy from human volunteers a competitive, reverse transcriptase PCR (RT-PCR) protocol was developed. Design: A randomised controlled, single blind cross over dietary study which compared the effects of a low level n-3 polyunsaturated fatty acids (PUFA) using normal foods enriched with eicosapentaenoic (EPA) and docosahexaenoic (DHA) (test diet), with non-enriched but otherwise identical foods (control). The diets were consumed for a period of 22 d with a wash out period of 5 months between the diets. Setting: Free-living individuals associated with the University of Surrey. Subjects: Six male subjects with a mean ( AE sd) age of 51.2 AE 3.6 y were recruited. Major Outcome Measures: Pre-and postprandial blood samples were taken for the measurement of triacylglycerol (TAG), postheparin LPL activity and adipose tissue samples for the measurement of LPL mRNA levels. Results: Mean LPL expression values were 4.12 6 10 5 molecules of LPL mRNA per ng total RNA on the control diet and 4.60 6 10 5 molecules of LPL mRNA per ng total RNA on the n-3 PUFA enriched (test) diet. There was no signi®cant difference between the levels of LPL expression following each diet, consistent with the lack of change in TAG levels in response to increased dietary n-3 PUFA intake. However, the change in LPL expression (Test ± Control diet) correlated signi®cantly with the change in fasting TAG levels (P 0.03, R À0.87 and R 2 0.75) and with the total area under the TAG-time response curve (P 0.003, R À0.96 and R 2 0.92) in individuals. Conclusions: These ®ndings, although based on a small number of subjects, suggest that LPL expression may be a determinant of plasma TAG levels. The development of this methodology should allow further elucidation of the effects of dietary manipulation and disease processes on lipid clearance and regulation in human subjects. Sponsorship: This work was funded by BBSRC.
Introduction
Lipoprotein lipase is a key enzyme in lipid metabolism which is rate limiting in the hydrolysis of circulating TAG (triacylglcerol) and thus the clearance of postprandial lipaemia. There is abundant epidemiological evidence that hypertriacylglyc-erolaemia and prolonged postprandial lipaemia are associated with an increased risk of ischaemic heart disease (Austin, 1991; Patsch et al, 1983) . Excessive duration or magnitude of postprandial lipaemia results in the accumulation of chylomicron remnant particles (formed following the hydrolysis of chylomicron TAG) which become cholesterol-enriched as a result of transfer of cholesteryl esters from high density lipoproteins (HDL) (Sethi et al, 1993) . Chylomicron remnants have been shown to be atherogenic in both in vivo (Zilversmit, 1979) and in vitro systems (Huff et al, 1991) , and their impaired removal is thought to be responsible for the increased prevalence of coronary artery disease in patients with Type III hyperlipidaemia (Durrington, 1993) . A further consequence of prolonged residence of TAG-rich lipoproteins in the circulation is the increased transfer of TAG on to HDL and low density lipoproteins (LDL), and their subsequent hydrolysis by hepatic lipase resulting in the formation of small dense HDL and LDL (Sethi et al, 1993) .
The n-3 PUFA, principally EPA and DHA, found in ®sh oils have potent effects on many aspects of metabolism and postprandial lipid metabolism in particular. Chronic ingestion of ®sh oils attenuates the normal postprandial TAG pro®le (Harris et al, 1988; Williams et al, 1992) . Fish oil fatty acids are poor substrates for very low density lipoprotein (VLDL) synthesis. Hepatic VLDL secretion is therefore decreased and, as a result of postprandial competition between chylomicrons and VLDL for LPL is reduced (Gibbons, 1990; Clarke & Jump, 1993) . In addition, we have shown that ®sh oils stimulate and activate LPL; human volunteers had signi®cantly raised post-heparin LPL activity when fed a ®sh oil-containing meal compared with a mixed oil meal when measured 12 h after the meal was consumed (Zampelas et al, 1994) . This work has recently been con®rmed by the ®ndings of Harris et al (1997) . We have also shown signi®cantly increased LPL gene expression in rat epididymal adipose tissue following a ®sh oil diet (Murphy et al, 1993) . Fish oils have also been shown to increase LPL activity in muscle (Herzberg & Rogerson, 1989; Baltzell et al, 1991) , and Monalto & Bensadoun (1993) have shown in vitro that n-3 PUFA increase the secretion of LPL from adipocytes. There is also evidence to suggest that n-3 PUFA activate a common cellular signalling pathway to the ®brate drugs (Sirtori et al, 1993) which are potent inducers of LPL activity (Klose et al, 1980) . In the past we have measured the expression of LPL in rat adipose tissue by a speci®c northern blot method (Murphy et al, 1993) , but this methodology did not have the sensitivity to measure the level of expression in small human samples (Chapman, 1996) . We have found that the level of LPL activity and expression in human adipose tissue is approximately 14% of that in rat adipose tissue (Chapman et al, 1998) . Therefore, in order to examine changes in LPL expression in human adipose tissue biopsies (approximately 500 mg), a more sensitive method of LPL quantitation using the polymerase chain reaction (PCR) was developed.
PCR was ®rst described by Saiki et al (1985) as a highly sensitive and speci®c method for the ampli®cation and subsequent detection of genomic sequences from very small amounts of DNA. The original technique has since been coupled with a reverse transcription (RT) step to facilitate the detection of RNA sequences. RT-PCR may also be used to quantitate gene expression accurately. Competitive RT-PCR is used to achieve precise quantitation of speci®c mRNA species, and involves the co-ampli®cation of a competitive RNA template (which uses the same primers as the target RNA template) with the target RNA in the same tube. The cDNA products of the target and competitive RNAs are distinguishable after ampli®ca-tion, and are visualized by gel electrophoresis. The target RNA is co-ampli®ed in the presence of competitor RNA covering a range of known concentrations. Following RT-PCR, the relative amounts of target cDNA versus competitive cDNA can be measured by densitometric analysis of photographic negatives of ethidium bromide stained gels. Since the starting concentration of the competitor cDNA is known, the initial concentration of the target mRNA can be determined.
In summary, RT-PCR not only offers the advantage of being up to 1000 times more sensitive than blot assays (Wang et al, 1989) but also involves the use of much smaller amounts of RNA than traditional blotting methods, and it can be used to accurately quantitate the number of molecules of the target RNA. It was for these reasons that we decided to develop a competitive RT-PCR method to measure LPL mRNA in small adipose tissue biopsies. This paper describes a competitive RT-PCR method that utilises the multispeci®c internal standard (competitor) developed by Laville et al (1996) for the assessment of LPL gene expression in adipose tissue.
The results of a dietary intervention study which investigated the effects of ®sh oil enriched foods on postprandial metabolism have been published (Lovegrove et al, 1997) . The current paper reports the LPL gene expression data from the adipose tissue biopsies taken from six of the subjects from this study.
Methods

Subject recruitment
Full subject details are given in Lovegrove et al (1997) . In brief six healthy male volunteers aged from 48 ± 57 y with a range of body mass indices (BMI) from 23kgam 2 were studied ( Table 1 ). The subjects' habitual fat consumption was between 35 ± 45% of total energy and they consumed less than 30 units of alcohol per week. The study was approved by the University of Surrey and the South West Surrey District Local Research Ethics committees, and all subjects gave written consent to participate.
Dietary Intervention
A dietary invervention was performed in a randomised, controlled, single blind, cross over design. For two periods of 22 days subjects were provided with food which was either enriched with n-3 PUFA (DHA and EPA) (test) or not-enriched (control). The periods of dietary intervention were separated by a 5 month wash-out period. The food items used were biscuits, bread, cake, ice-cream, low fat spread, mayonnaise, milk shake and milk shake powder, orange drink, pasta and vinaigrette dressing. The foods were enriched using a ®sh oil concentrate`ROPUFA' (Hoffman La Roche Ltd. Basel, Switzerland). In addition, the subjects were asked to consume 113 g of ®sh pate Â per week made with mackerel (n-3 enriched diet) or tuna (control diet). These foods were incorporated into the volunteers' diets by substitution and the aim was to achieve an intake of EPA and DHA of 1.8 gad.
Protocol of the clinical study
The full study protocol is described by Lovegrove et al (1997) , who examined nine subjects, six subjects from this nine volunteered for an adipose tissue biopsy and suf®cient sample was obtained for analysis. On the day following both periods of dietary intervention the volunteers attended the Clinical Investigation Unit at the Royal Surrey County Hospital at 0800 having fasted for 12 h. A fasting blood sample was taken via a cannula inserted into a forearm vein and the subjects then consumed a mixed meal containing 6.4 MJ energy, 43 g protein, 163 g carbohydrate and 82 g fat in the form of cheese sandwiches,`Frosties' and a mixture of milk and cream, and orange juice. The subjects remained resting for 8 h and blood samples were taken at 30 and 60 min postprandially and then hourly for 8 h. During this time the subjects consumed no foods but had free access to decaffeinated beverages (without milk or sugar) and diet drinks. Eight h after the meal, an adipose tissue biopsy was taken using a 12 gauge needle from the paraumbilical region of the abdomen under local anaesthesia (lignocaine, 5%). Adipose tissue was aspirated under suction into a 20 ml syringe. Following this the volunteers were given heparin (7500 U) intraveneously and a blood sample (5 ml) was taken after 15 min. This sample was used for the measurement of post-heparin LPL activity (PHLA). Blood samples were centrifuged at 553 6 g for 10 min in a bench top centrifuge, the plasma was removed, separated into aliquots and stored at À20 for TAG and À80 for measurements of LPL activity.
Analytical Procedures
Total RNA Extraction Total RNA was extracted by a single-step isolation using an acid guanidinium thiocyanate-phenol-chloroform mixture (Chomczynski & Sacchi, 1987) . Adipose tissue biopsies were placed immediately into ice-cold 3 ml aliquots of a solution`D' (containing 4 M guanidinium thiocyanate; 25 mM sodium citrate; 0.5% sarkosyl; 0.1 M 2-mercaptoethanol). Sodium acetate (300 ml, 2 M), 3 ml phenol (fresh, water saturated) and 600 ml of a chloroform: isoamylalcohol mixture (24 : 1) were added. The mixture was shaken vigorously for 20 sec and left on ice for 30 min. Following centrifugation at 6595 6 g for 20 min at 4 , the aqueous layer was removed and mixed with an equal volume of isopropanol. The tubes were left for 1 h at À20 and then centrifuged as before. The supernatant was discarded and the remaining pellet was dissolved in 300 ml solution`D' (without 2-mercaptoethanol) and the RNA precipitated by the addition of 600 ml 100% ethanol. The tubes were left at À20 overnight to aid precipitation of RNA and centrifuged at 4135 6 g for 20 min at room temperature to obtain a pellet of RNA. The pellet was washed with 75% ethanol (vav), re-centrifuged, decanted and left to dry, before being resuspended in 50 ml 0.5% (wav) sodium dodecyl sulphate. Total RNA was measured by absorption at 260 nm using the Genequant II microspectrophotometer (Pharmacia Biotech, St Albans, UK). Yields of total RNA from the adipose tissue biopsies ranged from 43ngaml. The absorption ratio (260 : 280) was between 1.85 and 2.0 for all preparations. RNA integrity was checked by establishing the presence of intact 18S and 28S ribosomal bands on an agarose gel.
Competitive RT-PCR
The competitive RT-PCR described here utilised the multispeci®c internal standard published by Laville et al (1996) and kindly donated by Professor Hubert Vidal. To produce a synthetic multispeci®c RNA standard from the vector (containing the multispeci®c internal standard) the following procedure was carried out. Firstly, the vector was cloned in E-coli (strain JM109). Single colonies from the agar plates were picked out and cultured in LB-media and ampicillin (50 mgaml) at 37 for 5 h. The vector DNA from the resulting culture was extracted using the Wizard Plus SV Minipreps DNA Puri®cation System (Promega, Southampton, UK). Endonuclease restriction digests were carried out using XhoI and BamHI enzymes to con®rm the presence of the multispeci®c standard (size 525 bp). A larger volume of LB media with ampicillin was prepared (500 ml) and 1.5 ml of cells from the single colony preparation were added. The culture was incubated at 37 overnight (no longer than 16 h). To extract the vector from the culture the Wizard Plus Maxiprep DNA puri®cation system (Promega) was used. Con®rmation that the multispeci®c standard was present was carried out by enconuclease restriction digestion as before. The vector was linearized using the enzyme BamHI and the DNA concentration measured spectrophotometrically at 260 nm. To produce a synthetic RNA standard, the linearized DNA phagemid was transcribed using the Ribomax Large Scale RNA Production system (Promega, Southampton, UK). The concentration of the synthetic RNA standard was measured spectrophotometrically by absorbance at 260 nm. Con®rmation of size was achieved by running out the RNA on an agarose gel (1.8% wav) alongside a known marker.
Competitive RT-PCR utilises oligonucleotide primers that will amplify both the standard (competitor) and target RNA in the same tube, but produces products of different sizes which can be separated by electrophoresis. The primers described by Laville et al (1996) produced a LPL competitor product of 267 bp in size and a LPL target product of 227 bp. The upstream (sense) and downstream (anti-sense) primers had the following sequences: Sense: 5 H -ACACAGCTGAGGACACTTGC-3 H and antisense: 5 H -CACTGGGTAATGCTCCTGAG-3
H . Competitive RT-PCR was performed using the Access RT-PCR System kit (Promega, Southampton, UK) according to the manufacturer's instructions. Limited amounts of sample dictated that 1 ml of total RNA sample was used in all reactions regardless of the concentration. MgSO4 (1 mM) was found to be optimal for these experiments and 50 pmol of both upstream and downstream primers were used. De®ned working solutions of the standard RNA (range 10 ng ± 100 fgaml) were added to give a gotal reaction volume of 50 ml. The RT-PCR was carried out in a Omn-E thermal cycler (Hybaid, Middlesex, UK) using the following conditions: Reverse transcription at 48 for 45 min, followed by denaturation at 94 for 30 s, annealing of primers at 60 for 1 min and extension at 68 for 2 min. The reaction products were separated on a 3% (wav) agarose gel, stained with ethidium bromide (0.3 mgal) and photographed on pos-neg ®lm (665 ®lm; Polaroid). The band densities were measured on the negative using a Dual wavelength¯ying spot scanner (Shimadzu Europa GMBH, Duisberg, Germany). After correction for the difference in nucleotide number, the density ratio of the target band to competitor band was plotted versus the reciprocal of the initial amount of competitor RNA (in number of molecules).
Control experiments that omitted RNA from the reaction were included in each PCR and were used to verify the absence of contamination. In order to compare samples as accurately as possible, the target mRNAs from both the control and ®sh oil studies were measured in the same run, using the same mastermix of reagents and amounts of competitor RNA taken from the same serial dilution. The RT-PCR experiments were repeated at least twice for each sample and the products for each experiment were run on two agarose gels in order to demonstrate reproducibility. Results were expressed as number of molecules of LPL LPL in human adipose tissue MC Murphy et al mRNAang total RNA and the coef®cient of variation was 22%.
Measurement of postherapin plasma LPL activity (PHLA) LPL activity was measured in 20 ml aliquots of plasma taken 15 min after the administration of an intravenous dose of heparin. Total activity was measured, with LPL activity being inhibited with 4 M sodium chloride by a modi®cation of the method described by Nilsson-Ehle and Schotz (1976) using the detection of liberated 3 H-labelled free fatty acids from a 3 H-labelled triolein substrate emulsion (Amersham International, Herts, UK.), as the index of triolein hydrolysis. Enzyme activity was expressed in mU where one mU represents nmol oleateamin per ml plasma at 37
. The intra-assay coef®cients of variation were 4.9% at 70 and 5.6% at 270 mU, and the inter-assay coef®cient of variation was 8.7% at 260 mU.
Measurement of TAG
Plasma TAG levels were assayed spectrophotometrically using a kit supplied by Roche Diagnostic Products Ltd., (Welwyn Garden City). The assay is an enzymatic colorimetric analysis using lipoprotein lipase, glycerol kinase and glycerol phosphate oxidase in the presence of peroxidase. Analyses were carried out using the Cobas Mira Plus analyser (Roche Products Ltd., Herts, UK) and the interassay coef®cient of variation was 1.8% at 3.26 mmolal.
Statistical Analysis
Mean and standard deviation were calculated for each measurement. The area under the TAG response curve was calculated using`Simpson's trapezoidal Rule' and the integrated area of the postprandial plasma TAG concentration time-response to the fact containing meal was expressed as min. mmol l
À1
. Statistical analysis of paired data using the Students t test, and Pearson's test for correlations coef®cients were calculated using Instat Version 2.1 for Macintosh. Values of P`0.05 were taken as the lowest level of signi®cance.
Results
The results from a typical competitive RT-PCR experiment are shown in Figure 1 . The competitor and target type bands are shown at 267 and 227 bp respectively. The twofold dilutions of the competitor RNA are shown over the range from 50 pg to 780 fg and the crossover point is around 3.13 pg competitor RNA.
The dietary intervention achieved a signi®cant mean increase (P`0.001) of n-3 PUFA intake on the enriched diet of 1.36 gaday of EPA and DHA compared to 0.37 gaday on the control diet. However, as reported by Lovegrove et al (1997) this level of enrichment, which was delivered by incorporating EPA and DHA into foods, failed to cause any signi®cant TAG lowering either of fasting values (Table 2) or post prandial levels (Table 3) despite signi®cant changes in plasma and phospholipid EPA and DHA levels also reported previously (Lovegrove et al, 1997) . In addition, there was no change in the levels of PHLA between the test and control diet ( Table 2) .
The mean expression of LPL mRNA molecules per ng total RNA was 4.12 6 10 5 AE 2.83 on the control diet and 4.60 6 10 5 AE 3.09 molecules of LPL mRNA per ng total RNA on the n-3 PUFA enriched (test) diet; this was not a signi®cant increase (P 0.78) and indeed, only 4 out of 6 subjects had higher expression on the enriched diet compared to the control diet as shown in Table 3 . Although only six subjects were studied, it was noted that the subject who responded to the n-3 PUFA supplement with a decrease in fasting TAG levels, had the greatest increase in LPL expression, whilst the subjects whose fasting TAG levels increased on n-3 PUFA supplementation showed decreased levels of LPL expression. There was a signi®cant correlation between the change in fasting TAG level (Test dietÐ Control diet) with the change in LPL expression (P 0.03, R À0.87 and R 2 0.75) (Figure 2 ). In addition, there was a highly signi®cant correlation between change in the total area under the postprandial TAG concentration-time response curve and the change in LPL expression (P 0.003, R À0.96 and R 2 0.92) ( Figure  3) . The results suggest that the change in LPL expression accounted for approximately 75% of the variance in fasting TAG levels and 92% of the variance of the change in the TAG-AUC. There was no signi®cant correlation between LPL expression and PHLA nor between the changes in these measurements from the control to the test diet, but there was a signi®cant negative correlation between the individual subjects' TAG-AUC and PHLA (n 11) (P`0.04, R À0.64, R 2 À0.40) (Figure 4 ).
Discussion
The RT-PCR method described in this paper has been shown to be both speci®c and sensitive enough to detect LPL in adipose tissue biopsies taken from free-living volunteers of normal body weight. Values of LPL expression obtained were between 0.6 and 8.05 6 10 5 molecules per ng total RNA. These are comparable with values calculated from the paper by Laville et al (1996) of LPL expression in human muscle ranging from approximately 7.8 to 23.4 6 10 5 molecules of LPL mRNA per ng total RNA in the basal state and, decreasing to between 3.0 to 19.8 6 10 5 molecules of LPL mRNA per ng total RNA following insulin infusion. This would suggest that LPL expression may be higher in muscle than adipose tissue. Figure 1 Competitive RT-PCR using a 2-fold serial dilution of the 372 bp LPL competitor RNA and a constant amount of the 442 bp target LPL mRNA. Lanes 1 and 11 contain a 1 Kb DNA ladder and lane 10 a 100 bp ladder. Lanes 2 ± 8 contain a 2-fold serial dilution of the LPL competitor ranging from 50 pg-780 fg. Lane 9 is the negative control. The approximate equivalence point is between lanes 5 and 7 (6.25 ± 1.56 pg competitor RNA). The arrows on the left hand side indicate the position of the competitor (267 bp) and the target PCR fragments (227 bp).
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However, the subjects studied by Laville et al (1996) were young men and women (aged 24 AE 1 year), and this difference may be a re¯ection of subjects' age or level of physical activity. Comparisons of LPL activity in adipose tissue and skeletal muscle from human subjects have indicated that there is tissue-speci®c regulation depending on the whether subjects are in a fed or fasted state (Farese et al, 1991) . In this latter study, LPL activities in adipose tissue and muscle were not signi®cantly different in the fasting state, whereas on feeding, adipose tissue LPL activity rose while activity levels in muscle fell. The nutritional status of the individual at the time of biopsy is therefore an important determinant of LPL activity and must be controlled if multiple measurements are to be made. Figure 2 The relationship between the change in LPL expression and the change in fasting TAG from the control to the n-3 PUFA enriched diet. Figure 3 The relationship between the change in LPL gene expression and the change in the total area under the TAG time-response curve from the control to the n-3 PUFA enriched diet.
This method was sensitive enough to carry out repeated RT-PCR experiments on the extracted RNA. However, due to the nature of adipose tissue, the clinical samples obtained contained very low concentrations of RNA and therefore the reference against which these have been quoted was total RNA measured spectrophotometrically. A different approach would have been to measure the change by relating the level of expression of the target gene against that of a`housekeeping gene'Ð so called because it remains at a constant level of expression regardless of cell cycle state, age of cell or external stimuli. However, this method is unsuitable for situation where an appropriate houskeeping gene has not been identi®ed or where limited amount of sample prohibit the extra reactions required. Both these problems were experienced in this work. There is no universally accepted house-keeping gene for adipose tissue, especially under conditions where dietary fat content has been altered, and this requires further investigation. In addition, unless adipose tissue is obtained under general anaesthetic it is extremely dif®cult to get suf®cient RNA from adipose tissue biopsies from non-obese volunteers to quantitatively assess more than one gene. Lovegrove et al (1997) suggested that the biological response to n-3 PUFA may be different depending on whether n-3 PUFA is given in capsule form or, as here, in foods enriched with EPA and DHA. In view of the lack of effect on plasma TAG response observed in this intervention study, it was not anticipated that any change in LPL gene expression would be observed and that further studies using higher doses of ®sh oils would be needed to examine this response further. This has been con®rmed by the lack of a consistent difference in LPL gene expression between the two diets. The signi®cant negative relationships between TAG levels (both fasting and TAG-AUC) and LPL gene expression warrants further investigation. These relationships suggest that LPL expression may be a determinant of fasting and postprandial TAG levels. Further examination of the underlying causes of changes in LPL expression in adipose tissue in individuals are needed. It may be postulated that the variation in LPL expression may result in the signi®cant degree of variability in terms of lipoprotein response to dietary modi®cation. This variability has been noted recently by Chamberlain et al (1998) , who examined the association between the response to dietary therapy and common restriction fragment length polymorphisms of LPL and hepatic lipase and failed to show any signi®cant associations.
The suggestion that LPL gene expression relates to TAG levels but not to PHLA, in the present study, appears to con¯ict with the proposal that LPL is a main determinant of plasma TAG levels. However, a lack of correlation between LPL expression in one tissue and total PHLA, can be explained on the basis that PHLA is not a tissue speci®c measurement, since a number of tissues contribute to LPL activity in the postheparin plasma. In addition, the release of LPL after heparin administration represents a single point, unphysiological stimuli. The negative correlation between PHLA and TAG-AUC, in the present study, ®ts with the ®ndings of Harris et al (1997) comparing LPL activity and fasting TAG levels. The relationship between PHLA and TAG-AUC suggest that PHLA levels re¯ect recent exposure to the substrate, plasma TAG, with the result that high levels of activity effectively clear TAG from the plasma. The fact that the changes in LPL expression are correlated to changes in plasma TAG and not changes in PHLA suggest that LPL expression is a longer term regulator of plasma lipid levels. LPL expression measurements over time, therefore, may be more indicative of inef®cient plasma TAG clearance than measurements of PHLA.
Conclusion
This paper presents preliminary evidence suggesting that changes in LPL expression are related to long term changes in plasma TAG levels. By extension, this suggests that factors which contribute to attenuation in LPL expression may be important factors in determining elevated fasting and postprandial TAG, now strongly implicated as risk factors in coronary heart disease. It is expected that the development of this method in the future will allow the examination of many factors affecting LPL expression and further elucidation of the role of this gene in regulating plasma TAG levels.
